Cargando…

Elevated Serum Cyclophilin D Level is Associated with Nonalcoholic Fatty Liver Disease and Higher Fibrosis Scores in Patients with Diabetes Mellitus

BACKGROUND: Cyclophilin D (CypD) is a mitochondrial matrix protein involved in liver steatosis and fibrosis in vitro. However, the role of CypD in the development of fatty liver and liver fibrosis in humans has not been determined. PURPOSE: To measure the serum level of CypD in patients with type 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naguib, Mervat, Abou Elfotouh, Mahmoud, Wifi, Mohamed-Naguib
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380628/ https://www.ncbi.nlm.nih.gov/pubmed/34434058 http://dx.doi.org/10.2147/IJGM.S322986

Ejemplares similares

COVID-induced pancreatitis: case report
por: Wifi, Mohamed-Naguib, et al.
Publicado: (2021)

Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis
por: Hegazy, Mona A, et al.
Publicado: (2019)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
por: Omran, Dalia, et al.
Publicado: (2018)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

Association of serum 25-hydroxyvitamin D(3) levels and insulin resistance with viral load and degree of liver fibrosis in Egyptian chronic HBV patients: a case-control study
por: Naguib, Rania, et al.
Publicado: (2022)

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
por: Jang, Byoung Kuk
Publicado: (2012)

Elevated Serum Cyclophilin B Levels Are Associated with the Prevalence and Severity of Metabolic Syndrome
por: Zhang, Hang, et al.
Publicado: (2017)

Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease
por: Kim, Min Chul, et al.
Publicado: (2020)

Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis
por: Chen, Hao-Kai, et al.
Publicado: (2023)

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Lee, Tae Hoon, et al.
Publicado: (2013)

Beclin1 circulating level as predictor of carotid intima-media thickness in patients with type 2 diabetes mellitus
por: Naguib, Mervat, et al.
Publicado: (2021)

Toll-like receptors-2 and -9 (TLR2 and TLR9) gene polymorphism in patients with type 2 diabetes and diabetic foot
por: Wifi, Mohamed-Naguib Abdalla, et al.
Publicado: (2017)

The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Dai, Chia-Yen, et al.
Publicado: (2022)

Does Serum Osteocalcin Level Affect Carotid Atherosclerosis in Post-Menopausal Diabetic Females? A Case-Control Study
por: Naguib, Mervat, et al.
Publicado: (2022)

Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease
por: Tokushige, Katsutoshi, et al.
Publicado: (2013)

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
por: Kosasih, Sumitro, et al.
Publicado: (2018)

Comments to Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Guan, Yong-Song
Publicado: (2014)

The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease
por: Alkhouri, Naim, et al.
Publicado: (2014)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Serum Ghrelin Concentration in Patients With Primary Biliary Cirrhosis (PBC)
por: Naguib, Rania, et al.
Publicado: (2021)

Evaluation of thyroid function and thyroid autoimmune disease in patients with non-alcoholic fatty liver disease
por: Naguib, Rania, et al.
Publicado: (2021)

Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults
por: Yang, Huan-Huan, et al.
Publicado: (2021)

Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis
por: Chen, Vincent L., et al.
Publicado: (2019)

Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease
por: Marella, Hemnishil K., et al.
Publicado: (2020)

Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome
por: Kositamongkol, Chayanis, et al.
Publicado: (2021)

Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease
por: Huang, Peng, et al.
Publicado: (2021)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Cyclophilins and cyclophilin inhibitors in nidovirus replication
por: de Wilde, Adriaan H., et al.
Publicado: (2018)

Risk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitus
por: Zhao, Hongli, et al.
Publicado: (2018)

Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
por: Barb, Diana, et al.
Publicado: (2021)

Evaluation of Serum Levels of Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Patients With Colorectal Cancer: A Case-Control Study
por: Naguib, Rania, et al.
Publicado: (2021)

Role of EUS in detection of liver metastasis not seen by computed tomography or magnetic resonance imaging during staging of pancreatic, gastrointestinal, and thoracic malignancies
por: Okasha, Hussein Hassan, et al.
Publicado: (2021)

Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2011)

Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
por: Song, Do Seon, et al.
Publicado: (2019)

Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021)

Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
por: Wang, Qi, et al.
Publicado: (2021)

Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease
por: Sun, Tiantian, et al.
Publicado: (2023)

Endoscopic intervention in a case proven latterly to be a COVID-19
por: Elkholy, Shaimaa, et al.
Publicado: (2020)

Protective effect of whey proteins against nonalcoholic fatty liver in rats
por: Hamad, Essam M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ccc9o51oc18o1qhabiljc5r3tg